Navigation Links
Heska Enters Distribution Agreement with MWI Veterinary Supply
Date:11/12/2012

LOVELAND, Colo., Nov. 12, 2012 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today a new distribution agreement with MWI Veterinary Supply.  MWI will inventory, market and promote the full line of Heska's veterinary products throughout the United States beginning January 2, 2013.  Certain products, such as the popular Vet/IV Infusion Pump, will be available through MWI immediately.

"We believe this partnership represents a significant opportunity," says Robert Grieve, Chairman and Chief Executive Officer of Heska Corporation.  "Improving the choices available for advanced diagnostic solutions will benefit both customers and the animal health industry as a whole, and improve business opportunities for both MWI and Heska."

"MWI is very pleased to offer our customers the additional solutions Heska's products provide.  We look forward to working with Heska as we continue our shared missions of serving veterinary professionals," said Jim Cleary, MWI President and Chief Executive Officer.

About Heska
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products.  Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines.  The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.  For further information on Heska and its products, visit the company's website at www.heska.com.

About MWI
MWI is a leading distributor of animal health products across the United States and the United Kingdom. MWI sells both companion animal and production animal products including pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, supplies, pet food, capital equipment and technologies used by veterinarians and producers.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. There are uncertainties regarding Heska's ability to successfully commercialize new products; competition, including new products competitors may introduce in the future; uncertainties related to Heska's market estimates; uncertainties regarding Heska's ability to gain market share in an economic manner; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Quarterly Report on Form 10-Q for the quarter ended June 30, 2012.


'/>"/>
SOURCE Heska Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Webcast Alert: Heska Announces Third Quarter 2012 Earnings Conference Call Webcast
2. Heska Corporation Announces Amendment To Its Odd-Lot Tender Offer
3. Heska to Present at B. Riley Investor Conference
4. Heska Announces Quarterly Dividend of $0.10 Per Share
5. Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers
6. Pharmalink Enters Manufacturing Agreement for Nefecon(R)
7. SAFC Enters South Korean BioPharma Market with CrystalGenomics Agreement
8. Surgical Equipment Market to 2018 - Increased Access to Ambulatory Surgical Centers to Drive Outpatient Surgery Volumes
9. Johnson & Johnson Announces Plans to Establish Innovation Centers
10. IBA Molecular Introduces Centers for Innovation
11. Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Womens Health Business to Meda
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan 17, 2017 Research and ... Market 2016-2020" report to their offering. ... The global laparotomy sponges market to ... Global Laparotomy Sponges Market 2016-2020, has been prepared ... The report covers the market landscape and its growth prospects over ...
(Date:1/17/2017)...  ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ... Quinn Ph.D as Vice President Corticotropin Regulatory Affairs, ... Karen Quinn is a professional with over ... Affairs, specifically with a focus on drug products ... most recently with Takeda Pharmaceuticals International as Senior ...
(Date:1/17/2017)... , Jan. 17, 2017  Bayer today announced the appointment ... Pharmaceuticals business in the Americas, comprising the United ... Latin America . In this role, Dr. ... the Board of Management of Bayer AG and President of ... highly respected leader in the pharmaceutical industry and I,m delighted ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... 2017 , ... Neil H. Greco Insurance Agency, a northern New Jersey firm ... is launching a charity drive to raise awareness of heart disease and promote habits ... America, and is responsible for 1 in every 4 deaths at the national level ...
(Date:1/17/2017)... ... January 17, 2017 , ... Physicians Education ... Lee as keynote speaker for the 34th Annual Miami Breast Cancer Conference®, on ... announcement, PER® president, Phil Talamo, said, “We are delighted to have Sandra Lee ...
(Date:1/17/2017)... ... January 17, 2017 , ... Twelve ... State University’s Athletic Training Education program forged a relationship built upon the foundation ... Program, which is consists of both student members and certified members of the ...
(Date:1/16/2017)... Village, IL (PRWEB) , ... January 16, 2017 ... ... personal audio products, will demonstrate their groundbreaking GunSport•PRO® and EB15•LE® electronic earplugs at ... Convention Center in Las Vegas, Booth #2809. The SHOT Show is the shooting, ...
(Date:1/16/2017)... ... January 16, 2017 , ... Permobil has just ... brand of custom seating systems has a well-earned reputation for premium quality, with ... for innovation and growth in the custom seating business, which enjoys strong demand, ...
Breaking Medicine News(10 mins):